Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary.

about

Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer.The HNF-1β-USP28-Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma.

P2860

Q47122646-8B4EC61D-F79E-4794-AF0A-C61C61DD116D Q52715782-84BD5F35-7467-4EC7-B55B-BA9C9F1B5281

P2860

Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary.

Item

http://www.wikidata.org/entity/Q35870176

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Checkpoint kinase 1 inhibitors ...... r cell carcinoma of the ovary.

@ast

Checkpoint kinase 1 inhibitors ...... r cell carcinoma of the ovary.

@en

type

Item

label

Checkpoint kinase 1 inhibitors ...... r cell carcinoma of the ovary.

@ast

Checkpoint kinase 1 inhibitors ...... r cell carcinoma of the ovary.

@en

prefLabel

Checkpoint kinase 1 inhibitors ...... r cell carcinoma of the ovary.

@ast

Checkpoint kinase 1 inhibitors ...... r cell carcinoma of the ovary.

@en

P1476

Checkpoint kinase 1 inhibitors ...... r cell carcinoma of the ovary.

@en

P2093

Chiharu Yoshimoto

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kobayashi

http://www.w3.org/2001/XMLSchema#string

Hiroshi Shigetomi

http://www.w3.org/2001/XMLSchema#string

P2860

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer

Oxidative stress, inflammation, and cancer: how are they linked?

A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.

Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells.

Hydroxyl radicals and DNA base damage.

Relationship between epidemiologic risk factors and hormone receptor expression in ovarian cancer: results from the Nurses' Health Study.

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.

New insights into checkpoint kinase 1 in the DNA damage response signaling network.

Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.

Mysterious link between iron overload and CDKN2A/2B.

P304

571-576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2015.3268

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277944379

http://www.w3.org/2001/XMLSchema#string

P698

26622535

http://www.w3.org/2001/XMLSchema#string

P932

4508996

http://www.w3.org/2001/XMLSchema#string

Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary.

about

P2860

P2860

Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932